Scarica l'app Stockscreener
12.91
0.31%
-0.04
Carlsmed Inc Borsa (CARL) Ultime notizie
Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise - Investing.com UK
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery - Yahoo Finance
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - Ortho Spine News
Carlsmed launches personalized cervical fusion implant system By Investing.com - Investing.com Nigeria
Carlsmed launches personalized cervical fusion implant system - Investing.com
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting - GlobeNewswire Inc.
Comparing Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) - Defense World
Carlsmed, Inc. Stock (I82)Quote Deutsche Boerse AG - MarketScreener
Carlsmed, Inc.: Dividend historical data and projections - MarketScreener
Carlsmed, Inc.: Financial Data Forecasts Estimates and Expectations | I82 | US14280C1053 - MarketScreener
Carlsmed, Inc.: Revenue and Earnings Analysts Forecasts Revisions | I82 | US14280C1053 - MarketScreener
Carlsmed Stock: Back To Where We Started (NASDAQ:CARL) - Seeking Alpha
Discontinued operations of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed, Inc. Cash Flow – FWB:I82 - TradingView
Basic earnings per share (basic EPS) of Carlsmed, Inc. – FWB:I82 - TradingView
Carlsmed Reports Strong Q3 Growth and Raises Guidance - MSN
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Carlsmed (NASDAQ:CARL) Raised to Hold at Wall Street Zen - MarketBeat
Bioventus (NASDAQ:BVS) & Carlsmed (NASDAQ:CARL) Critical Contrast - Defense World
Truist Financial Reaffirms Buy Rating for Carlsmed (NASDAQ:CARL) - MarketBeat
BTIG Research Increases Carlsmed (NASDAQ:CARL) Price Target to $24.00 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Carlsmed, Inc. (CARL), Brookdale Senior Living (BKD) and Eton Pharmaceuticals (ETON) - The Globe and Mail
Carlsmed (NASDAQ:CARL) Announces Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
BTIG Maintains Carlsmed (CARL) Buy Recommendation - Nasdaq
Carlsmed stock price target raised to $24 by BTIG on strong Q3 results - Investing.com South Africa
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance - The Manila Times
Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth By Investing.com - Investing.com Nigeria
Earnings call transcript: Carlsmed Q3 2025 sees 98% revenue growth - Investing.com
Carlsmed Secures $60 Million Credit Facility Amendment - MSN
Carlsmed, Inc. (CARL) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Carlsmed, Inc. (NASDAQ:CARL) Sees Significant Decrease in Short Interest - MarketBeat
Carlsmed, Inc. (CARL) Stock Price, News, Quote & History - Yahoo! Finance Canada
carlsmed, inc. Earnings dates - RTTNews
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025 | User | thepilotnews.com - FinancialContent
Carlsmed, Inc.Common Stock (Nasdaq:CARL) Stock Quote - FinancialContent
Carlsmed, Inc. (NASDAQ:CARL) Short Interest Update - MarketBeat
Carlsmed (NASDAQ:CARL) Now Covered by Weiss Ratings - MarketBeat
ETFs Investing in Carlsmed, Inc. Stocks - TradingView
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Earnings Preview: Carlsmed to Report Financial Results Post-market on August 28 - 富途牛牛
Carlsmed appoints Jennifer Kamocsay as CLO, secretary - MSN
CARL Financial Statements & ChartsCarlsmed Inc MacroTrends - CMLviz
People moves: Michael Kaplan rejoins StandardAero as legal chief as Jenifer Kamocsay moves over to Carlsmed - | Governance Intelligence
1.94%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):